Article Details
Retrieved on: 2025-03-22 19:13:56
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article emphasizes the growth of the cell line development market, driven by rising demand for biopharmaceuticals, including biosimilars, and monoclonal antibodies. This aligns with the biopharma concept and tags such as Biotechnology, Biopharmaceutical, and Biomanufacturing. Key players like Lonza Group and Samsung Biologics also relate to these advancements.
Article found on: www.openpr.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here